The use of acetazolamide in idiopathic intracranial hypertension during pregnancy

Andrew G. Lee, Misha Pless, Julie Falardeau, Tammy Capozzoli, Michael Wall, Randy H. Kardon

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

• PURPOSE: To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH). • DESIGN: Observational case series. • METHODS: SETTING: Two tertiary care academic neuro-ophthalmology units. PATIENT POPULATION: Patients with IIH treated with acetazolamide. OBSERVATION PROCEDURE: Documentation of pregnancy outcome. MAIN OUTCOME MEASURES: Normal pregnancy, fetal loss, or congenital malformation. • RESULTS: Twelve patients were treated with acetazolamide for IIH during pregnancy, and there were no adverse pregnancy outcomes. A critical review of the English language literature on the subject failed to demonstrate any convincing evidence for any adverse effect on pregnancy for acetazolamide. • CONCLUSIONS: Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.

Original languageEnglish (US)
Pages (from-to)855-859
Number of pages5
JournalAmerican Journal of Ophthalmology
Volume139
Issue number5
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Pseudotumor Cerebri
Acetazolamide
Pregnancy Outcome
Pregnancy
Ophthalmology
Tertiary Healthcare
Informed Consent
Pharmaceutical Preparations
Documentation
Language
Observation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. / Lee, Andrew G.; Pless, Misha; Falardeau, Julie; Capozzoli, Tammy; Wall, Michael; Kardon, Randy H.

In: American Journal of Ophthalmology, Vol. 139, No. 5, 04.2005, p. 855-859.

Research output: Contribution to journalArticle

Lee, Andrew G. ; Pless, Misha ; Falardeau, Julie ; Capozzoli, Tammy ; Wall, Michael ; Kardon, Randy H. / The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. In: American Journal of Ophthalmology. 2005 ; Vol. 139, No. 5. pp. 855-859.
@article{25392fb949f24548909ecdd0d6ef52e2,
title = "The use of acetazolamide in idiopathic intracranial hypertension during pregnancy",
abstract = "• PURPOSE: To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH). • DESIGN: Observational case series. • METHODS: SETTING: Two tertiary care academic neuro-ophthalmology units. PATIENT POPULATION: Patients with IIH treated with acetazolamide. OBSERVATION PROCEDURE: Documentation of pregnancy outcome. MAIN OUTCOME MEASURES: Normal pregnancy, fetal loss, or congenital malformation. • RESULTS: Twelve patients were treated with acetazolamide for IIH during pregnancy, and there were no adverse pregnancy outcomes. A critical review of the English language literature on the subject failed to demonstrate any convincing evidence for any adverse effect on pregnancy for acetazolamide. • CONCLUSIONS: Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.",
author = "Lee, {Andrew G.} and Misha Pless and Julie Falardeau and Tammy Capozzoli and Michael Wall and Kardon, {Randy H.}",
year = "2005",
month = "4",
doi = "10.1016/j.ajo.2004.12.091",
language = "English (US)",
volume = "139",
pages = "855--859",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - The use of acetazolamide in idiopathic intracranial hypertension during pregnancy

AU - Lee, Andrew G.

AU - Pless, Misha

AU - Falardeau, Julie

AU - Capozzoli, Tammy

AU - Wall, Michael

AU - Kardon, Randy H.

PY - 2005/4

Y1 - 2005/4

N2 - • PURPOSE: To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH). • DESIGN: Observational case series. • METHODS: SETTING: Two tertiary care academic neuro-ophthalmology units. PATIENT POPULATION: Patients with IIH treated with acetazolamide. OBSERVATION PROCEDURE: Documentation of pregnancy outcome. MAIN OUTCOME MEASURES: Normal pregnancy, fetal loss, or congenital malformation. • RESULTS: Twelve patients were treated with acetazolamide for IIH during pregnancy, and there were no adverse pregnancy outcomes. A critical review of the English language literature on the subject failed to demonstrate any convincing evidence for any adverse effect on pregnancy for acetazolamide. • CONCLUSIONS: Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.

AB - • PURPOSE: To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH). • DESIGN: Observational case series. • METHODS: SETTING: Two tertiary care academic neuro-ophthalmology units. PATIENT POPULATION: Patients with IIH treated with acetazolamide. OBSERVATION PROCEDURE: Documentation of pregnancy outcome. MAIN OUTCOME MEASURES: Normal pregnancy, fetal loss, or congenital malformation. • RESULTS: Twelve patients were treated with acetazolamide for IIH during pregnancy, and there were no adverse pregnancy outcomes. A critical review of the English language literature on the subject failed to demonstrate any convincing evidence for any adverse effect on pregnancy for acetazolamide. • CONCLUSIONS: Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.

UR - http://www.scopus.com/inward/record.url?scp=18144384705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144384705&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.12.091

DO - 10.1016/j.ajo.2004.12.091

M3 - Article

C2 - 15860291

AN - SCOPUS:18144384705

VL - 139

SP - 855

EP - 859

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -